Researchers are studying autism, a brain disease, by turning skin cells into brain cells through genetic manipulation, Philip Schwartz, Ph.D., a senior scientist at CHOC Research Institute, tells “American Health Journal.”
Scientists are using these cells with a goal to develop drug therapies for autism, as well as a diagnostic tool for the disorder, Dr. Schwartz says.
Learn more about autism research in “American Health Journal,” a television program that airs on PBS and other national network affiliates that reach more than 30 million households.
Each 30-minute episode features six segments with a diverse range of medical specialists discussing a full spectrum of health topics. For more information, visit www.discoverhealth.tv.
Philip Schwartz, Ph.D., is nationally recognized for his research in the stem cell field. His research focuses on the use of stem cells to understand the neurobiological causes of autism and other neurodevelopmental disorders. With funding support from CHOC, Dr. Schwartz established the National Human Neural Stem Cell Resource (NHNSCR) in 2001 to support national research in the field of neural stem cells by providing a reliable source for these cells to investigators nationwide
Get more information about referring patients to CHOC, including referral information directory, services directory and referral guidelines.
